Centers for Disease C, Prevention. Comorbidity in adults with epilepsy--United States, 2010. MMWR Morb Mortal Wkly Rep. 2013;62(43):849–53.
Google Scholar
Fiest KM, Sauro KM, Wiebe S, Patten SB, Kwon CS, Dykeman J, et al. Prevalence and incidence of epilepsy: a systematic review and meta-analysis of international studies. Neurology. 2017;88(3):296–303.
Article
PubMed
PubMed Central
Google Scholar
Gu L, Liang B, Chen Q, Long J, Xie J, Wu G, et al. Prevalence of epilepsy in the People’s Republic of China: a systematic review. Epilepsy Res. 2013;105(1–2):195–205.
Article
PubMed
Google Scholar
Verrotti A, D'Egidio C, Mohn A, Coppola G, Parisi P, Chiarelli F. Antiepileptic drugs, sex hormones, and PCOS. Epilepsia. 2011;52(2):199–211.
CAS
PubMed
Google Scholar
Tricco AC, Cogo E, Angeliki VA, Soobiah C, Hutton B, Hemmelgarn BR, et al. Comparative safety of anti-epileptic drugs among infants and children exposed in utero or during breastfeeding: protocol for a systematic review and network meta-analysis. Syst Rev. 2014;3:68.
Article
PubMed
PubMed Central
Google Scholar
Meador KJ, Loring DW. Developmental effects of antiepileptic drugs and the need for improved regulations. Neurology. 2016;86(3):297–306.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kapoor D, Wallace S. Trends in maternal deaths from epilepsy in the United Kingdom: a 30-year retrospective review. Obstet Med. 2014;7(4):160–4.
Article
PubMed
PubMed Central
Google Scholar
Edey S, Moran N, Nashef L. SUDEP and epilepsy-related mortality in pregnancy. Epilepsia. 2014;55(7):e72–4.
Article
CAS
PubMed
Google Scholar
Sukumaran SC, Sarma PS, Thomas SV. Polytherapy increases the risk of infertility in women with epilepsy. Neurology. 2010;75(15):1351–5.
Article
PubMed
Google Scholar
Bilo L, Meo R, Valentino R, Di Carlo C, Striano S, Nappi C. Characterization of reproductive endocrine disorders in women with epilepsy. J Clin Endocrinol Metab. 2001;86(7):2950–6.
Article
CAS
PubMed
Google Scholar
Zhou JQ, Zhou LM, Chen LJ, Han JD, Wang Q, Fang ZY, et al. Polycystic ovary syndrome in patients with epilepsy: a study in 102 Chinese women. Seizure. 2012;21(9):729–33.
Article
PubMed
Google Scholar
Hamed SA. The effect of epilepsy and antiepileptic drugs on sexual, reproductive and gonadal health of adults with epilepsy. Expert Rev Clin Pharmacol. 2016;9(6):807–19.
Article
CAS
PubMed
Google Scholar
Tomson T, Battino D, Perucca E. Valproic acid after five decades of use in epilepsy: time to reconsider the indications of a time-honoured drug. Lancet Neurol. 2016;15(2):210–8.
Article
CAS
PubMed
Google Scholar
Day FR, Hinds DA, Tung JY, Stolk L, Styrkarsdottir U, Saxena R, et al. Causal mechanisms and balancing selection inferred from genetic associations with polycystic ovary syndrome. Nat Commun. 2015;6:8464.
Article
CAS
PubMed
Google Scholar
Herzog AG, Schachter SC. Valproate and the polycystic ovarian syndrome: final thoughts. Epilepsia. 2001;42(3):311–5.
Article
CAS
PubMed
Google Scholar
Celik C, Tasdemir N, Abali R, Bastu E, Yilmaz M. Progression to impaired glucose tolerance or type 2 diabetes mellitus in polycystic ovary syndrome: a controlled follow-up study. Fertil Steril. 2014;101(4):1123–1128.e1121.
Article
CAS
PubMed
Google Scholar
Fearnley EJ, Marquart L, Spurdle AB, Weinstein P, Webb PM, Australian Ovarian Cancer Study G, et al. Polycystic ovary syndrome increases the risk of endometrial cancer in women aged less than 50 years: an Australian case-control study. Cancer Causes Control. 2010;21(12):2303–8.
Article
PubMed
Google Scholar
Rai D, Kerr MP, McManus S, Jordanova V, Lewis G, Brugha TS. Epilepsy and psychiatric comorbidity: a nationally representative population-based study. Epilepsia. 2012;53(6):1095–103.
Article
PubMed
Google Scholar
Kaufman KR. Epilepsy and secondary perceived stigma in a social setting: a night at the theater. Epilepsy Behav. 2016;61:138–40.
Article
PubMed
Google Scholar
Fabris RR, Cascino TG, Mandrekar J, Marsh WR, Meyer FB, Cascino GD. Drug-resistant focal epilepsy in women of childbearing age: reproduction and the effect of epilepsy surgery. Epilepsy Behav. 2016;60:17–20.
Article
PubMed
Google Scholar
Zelena V, Kuba R, Soska V, Rektor I. Depression as a prominent cause of sexual dysfunction in women with epilepsy. Epilepsy Behav. 2011;20(3):539–44.
Article
PubMed
Google Scholar
Borgelt LM, Hart FM, Bainbridge JL. Epilepsy during pregnancy: focus on management strategies. Int J Women’s Health. 2016;8:505–17.
Article
Google Scholar
Schwenkhagen AM, Stodieck SR. Which contraception for women with epilepsy? Seizure. 2008;17(2):145–50.
Article
PubMed
Google Scholar
Sabers A, Ohman I, Christensen J, Tomson T. Oral contraceptives reduce lamotrigine plasma levels. Neurology. 2003;61(4):570–1.
Article
CAS
PubMed
Google Scholar
Christensen J, Petrenaite V, Atterman J, Sidenius P, Ohman I, Tomson T, et al. Oral contraceptives induce lamotrigine metabolism: evidence from a double-blind, placebo-controlled trial. Epilepsia. 2007;48(3):484–9.
Article
CAS
PubMed
Google Scholar
Spona J, Elstein M, Feichtinger W, Sullivan H, Ludicke F, Muller U, et al. Shorter pill-free interval in combined oral contraceptives decreases follicular development. Contraception. 1996;54(2):71–7.
Article
CAS
PubMed
Google Scholar
Li J, Temmerman M, Chen Q, Xu J, Hu L, Zhang WH. A review of contraceptive practices among married and unmarried women in China from 1982 to 2010. Eur J Contracept Reprod Health Care. 2013;18(3):148–58.
Article
PubMed
Google Scholar
Zheng X, Tan L, Ren Q, Cui Z, Wu J, Lin T, et al. Trends in contraceptive patterns and behaviors during a period of fertility transition in China: 1988-2006. Contraception. 2012;86(3):204–13.
Article
PubMed
Google Scholar
Zeng J, Zou G, Song X, Ling L. Contraceptive practices and induced abortions status among internal migrant women in Guangzhou, China: a cross-sectional study. BMC Public Health. 2015;15:552.
Article
PubMed
PubMed Central
Google Scholar
Pittschieler S, Brezinka C, Jahn B, Trinka E, Unterberger I, Dobesberger J, et al. Spontaneous abortion and the prophylactic effect of folic acid supplementation in epileptic women undergoing antiepileptic therapy. J Neurol. 2008;255(12):1926–31.
Article
CAS
PubMed
Google Scholar
Meador KJ, Baker GA, Browning N, Cohen MJ, Clayton-Smith J, Kalayjian LA, et al. Foetal antiepileptic drug exposure and verbal versus non-verbal abilities at three years of age. Brain. 2011;134(Pt 2):396–404.
Article
PubMed
PubMed Central
Google Scholar
Shannon GD, Alberg C, Nacul L, Pashayan N. Preconception healthcare and congenital disorders: systematic review of the effectiveness of preconception care programs in the prevention of congenital disorders. Matern Child Health J. 2014;18(6):1354–79.
Article
PubMed
Google Scholar
Dansky LV, Rosenblatt DS, Andermann E. Mechanisms of teratogenesis: folic acid and antiepileptic therapy. Neurology. 1992;42(4 Suppl 5):32–42.
CAS
PubMed
Google Scholar
Diagnosis and management of epilepsy in adults. Scottish Intercollegiate Guidelines Network; 2015. http://www.sign.ac.uk/sign-143-diagnosis-and-management-of-epilepsy-in-adults.html. Accessed 25 Dec 2017.
Epilepsy in pregnancy. Royal College of Obstetricians and Gynaecologists; 2016. https://www.rcog.org.uk/globalassets/documents/guidelines/green-top-guidelines/gtg68_epilepsy.pdf. Accessed 25 Dec 2017.
Harden CL, Meador KJ, Pennell PB, Hauser WA, Gronseth GS, French JA, et al. Practice parameter update: management issues for women with epilepsy--focus on pregnancy (an evidence-based review): teratogenesis and perinatal outcomes: report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society. Neurology. 2009;73(2):133–41.
Article
CAS
PubMed
PubMed Central
Google Scholar
Cramer JAGJ, Schachter S, Devinsky O. Women with epilepsy: hormonal issues from menarche through menopause. Epilepsy Behav. 2007;11(2):160–78.
Article
PubMed
Google Scholar
Epilepsies: diagnosis and management. National Institute for Health and Care Excellence; 2016. https://www.nice.org.uk/guidance/cg137. Accessed 25 Dec 2017.
Hao N, Xia W, Tang Y, Wu M, Jiang H, Lin X, et al. Periconceptional folic acid supplementation among pregnant women with epilepsy in a developing country: a retroprospective survey in China. Epilepsy Behav. 2015;44:27–34.
Article
PubMed
Google Scholar
Berg MJ, Fischer LJ, Rivey MP, Vern BA, Lantz RK, Schottelius DD. Phenytoin and folic acid interaction: a preliminary report. Ther Drug Monit. 1983;5(4):389–94.
Article
CAS
PubMed
Google Scholar
Berg MJ, Ebert BE, Rivey MP, Schottelius DD. Utilization of Km for phenytoin dosage after folate addition to patient regimen. Ther Drug Monit. 1987;9(3):304–5.
Article
CAS
PubMed
Google Scholar
Steinweg DL, Bentley ML. Seizures following reduction in phenytoin level after orally administered folic acid. Neurology. 2005;64(11):1982.
Article
PubMed
Google Scholar
Girotto F, Scott L, Avchalumov Y, Harris J, Iannattone S, Drummond-Main C, et al. High dose folic acid supplementation of rats alters synaptic transmission and seizure susceptibility in offspring. Sci Rep. 2013;3:1465.
Article
PubMed
PubMed Central
CAS
Google Scholar
Pickell L, Brown K, Li D, Wang XL, Deng L, Wu Q, et al. High intake of folic acid disrupts embryonic development in mice. Birth Defects Res A Clin Mol Teratol. 2011;91(1):8–19.
Article
CAS
PubMed
Google Scholar
Mikati MA, Holmes GL, Chronopoulos A, Hyde P, Thurber S, Gatt A, et al. Phenobarbital modifies seizure-related brain injury in the developing brain. Ann Neurol. 1994;36(3):425–33.
Article
CAS
PubMed
Google Scholar
Hatta T, Ohmori H, Murakami T, Takano M, Yamashita K, Yasuda M. Neurotoxic effects of phenytoin on postnatal mouse brain development following neonatal administration. Neurotoxicol Teratol. 1999;21(1):21–8.
Article
CAS
PubMed
Google Scholar
Vorhees CV, Acuff KD, Weisenburger WP, Minck DR. Teratogenicity of carbamazepine in rats. Teratology. 1990;41(3):311–7.
Article
CAS
PubMed
Google Scholar
Bittigau P, Sifringer M, Genz K, Reith E, Pospischil D, Govindarajalu S, et al. Antiepileptic drugs and apoptotic neurodegeneration in the developing brain. Proc Natl Acad Sci U S A. 2002;99(23):15089–94.
Article
CAS
PubMed
PubMed Central
Google Scholar
Bittigau P, Sifringer M, Ikonomidou C. Antiepileptic drugs and apoptosis in the developing brain. Ann N Y Acad Sci. 2003;993:103–14 discussion 123-104.
Article
CAS
PubMed
Google Scholar
Forcelli PA, Janssen MJ, Vicini S, Gale K. Neonatal exposure to antiepileptic drugs disrupts striatal synaptic development. Ann Neurol. 2012;72(3):363–72.
Article
CAS
PubMed
PubMed Central
Google Scholar
Hill DS, Wlodarczyk BJ, Palacios AM, Finnell RH. Teratogenic effects of antiepileptic drugs. Expert Rev Neurother. 2010;10(6):943–59.
Article
CAS
PubMed
PubMed Central
Google Scholar
Tomson T, Battino D, Bonizzoni E, Craig J, Lindhout D, Sabers A, et al. Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry. Lancet Neurol. 2011;10(7):609–17.
Article
CAS
PubMed
Google Scholar
Campbell E, Kennedy F, Russell A, Smithson WH, Parsons L, Morrison PJ, et al. Malformation risks of antiepileptic drug monotherapies in pregnancy: updated results from the UK and Ireland Epilepsy and Pregnancy Registers. J Neurol Neurosurg Psychiatry. 2014;85(9):1029–34.
Article
CAS
PubMed
Google Scholar
Veroniki AA, Cogo E, Rios P, Straus SE, Finkelstein Y, Kealey R, et al. Comparative safety of anti-epileptic drugs during pregnancy: a systematic review and network meta-analysis of congenital malformations and prenatal outcomes. BMC Med. 2017;15(1):95.
Article
PubMed
PubMed Central
CAS
Google Scholar
Razaz N, Tomson T, Wikstrom AK, Cnattingius S. Association between pregnancy and perinatal outcomes among women with epilepsy. JAMA Neurol. 2017;74(8):983–91.
Article
PubMed
PubMed Central
Google Scholar
Yeh CC, Lussier EC, Sun YT, Lan TY, Yu HY, Chang TY. Antiepileptic drug use among women from the Taiwanese registry of epilepsy and pregnancy: obstetric complications and fetal malformation outcomes. PLoS One. 2017;12(12):e0189497.
Article
PubMed
PubMed Central
CAS
Google Scholar
Tomson T, Marson A, Boon P, Canevini MP, Covanis A, Gaily E, et al. Valproate in the treatment of epilepsy in girls and women of childbearing potential. Epilepsia. 2015;56(7):1006–19.
Article
CAS
PubMed
Google Scholar
Tomson T, Battino D, Bonizzoni E, Craig J, Lindhout D, Perucca E, et al. Dose-dependent teratogenicity of valproate in mono- and polytherapy: an observational study. Neurology. 2015;85(10):866–72.
Article
CAS
PubMed
Google Scholar
Thomas SV, Jose M, Divakaran S, Sankara Sarma P. Malformation risk of antiepileptic drug exposure during pregnancy in women with epilepsy: results from a pregnancy registry in South India. Epilepsia. 2017;58(2):274–81.
Article
CAS
PubMed
Google Scholar
He S, Zhu H, Qiu X, Zhu X, Peng A, Duan J, et al. Pregnancy outcome in women with epilepsy in Western China: a prospective hospital based study. Epilepsy Behav. 2017;74:10–4.
Article
PubMed
Google Scholar
Fujimura K, Mitsuhashi T, Takahashi T. Adverse effects of prenatal and early postnatal exposure to antiepileptic drugs: validation from clinical and basic researches. Brain Dev. 2017;39(8):635–43.
Article
PubMed
Google Scholar
Meador KJ, Baker GA, Browning N, Cohen MJ, Bromley RL, Clayton-Smith J, et al. Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study. Lancet Neurol. 2013;12(3):244–52.
Article
CAS
PubMed
PubMed Central
Google Scholar
Baker GA, Bromley RL, Briggs M, Cheyne CP, Cohen MJ, Garcia-Finana M, et al. IQ at 6 years after in utero exposure to antiepileptic drugs: a controlled cohort study. Neurology. 2015;84(4):382–90.
Article
CAS
PubMed
PubMed Central
Google Scholar
Bromley RL, Mawer GE, Briggs M, Cheyne C, Clayton-Smith J, Garcia-Finana M, et al. The prevalence of neurodevelopmental disorders in children prenatally exposed to antiepileptic drugs. J Neurol Neurosurg Psychiatry. 2013;84(6):637–43.
Article
PubMed
Google Scholar
Bromley RL, Calderbank R, Cheyne CP, Rooney C, Trayner P, Clayton-Smith J, et al. Cognition in school-age children exposed to levetiracetam, topiramate, or sodium valproate. Neurology. 2016;87(18):1943–53.
Article
CAS
PubMed
Google Scholar
Veiby G, Daltveit AK, Schjolberg S, Stoltenberg C, Oyen AS, Vollset SE, et al. Exposure to antiepileptic drugs in utero and child development: a prospective population-based study. Epilepsia. 2013;54(8):1462–72.
Article
PubMed
PubMed Central
Google Scholar
Christensen J, Gronborg TK, Sorensen MJ, Schendel D, Parner ET, Pedersen LH, et al. Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism. JAMA. 2013;309(16):1696–703.
Article
CAS
PubMed
PubMed Central
Google Scholar
Shallcross R, Bromley RL, Cheyne CP, Garcia-Finana M, Irwin B, Morrow J, et al. In utero exposure to levetiracetam vs valproate: development and language at 3 years of age. Neurology. 2014;82(3):213–21.
Article
CAS
PubMed
Google Scholar
Kasradze S, Gogatishvili N, Lomidze G, Ediberidze T, Lazariashvili M, Khomeriki K, et al. Cognitive functions in children exposed to antiepileptic drugs in utero - study in Georgia. Epilepsy Behav. 2017;66:105–12.
Article
PubMed
Google Scholar
Blotière PO, Raguideau F, Weill A, Elefant E, Perthus I, Goulet V, et al. Risks of 23 specific malformations associated with prenatal exposure to 10 antiepileptic drugs. Neurology. 2019;93(2):e167–80.
Article
PubMed
PubMed Central
CAS
Google Scholar
Cantwell R, Clutton-Brock T, Cooper G, Dawson A, Drife J, Garrod D, et al. Saving mothers’ lives: reviewing maternal deaths to make motherhood safer: 2006-2008. The eighth report of the confidential enquiries into maternal deaths in the United Kingdom. BJOG. 2011;118(Suppl 1):1–203.
PubMed
Google Scholar
Battino D, Tomson T, Bonizzoni E, Craig J, Lindhout D, Sabers A, et al. Seizure control and treatment changes in pregnancy: observations from the EURAP epilepsy pregnancy registry. Epilepsia. 2013;54(9):1621–7.
Article
CAS
PubMed
Google Scholar
Vajda FJ, O'Brien T, Lander C, Graham J, Eadie M. The efficacy of the newer antiepileptic drugs in controlling seizures in pregnancy. Epilepsia. 2014;55(8):1229–34.
Article
CAS
PubMed
Google Scholar
Martinez Ferri M, Pena Mayor P, Perez Lopez-Fraile I, Escartin Siquier A, Martin Moro M, Forcadas Berdusan M, et al. Comparative study of antiepileptic drug use during pregnancy over a period of 12 years in Spain. Efficacy of the newer antiepileptic drugs lamotrigine, levetiracetam, and oxcarbazepine. Neurologia (Engl Ed). 2018;33(2):78–84.
Vajda FJE, O'Brien TJ, Graham JE, Hitchcock AA, Lander CM, Eadie MJ. Predicting epileptic seizure control during pregnancy. Epilepsy Behav. 2018;78:91–5.
Article
PubMed
Google Scholar
Harden CL, Hopp J, Ting TY, Pennell PB, French JA, Hauser WA, et al. Practice parameter update: management issues for women with epilepsy--focus on pregnancy (an evidence-based review): obstetrical complications and change in seizure frequency: report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society. Neurology. 2009;73(2):126–32.
Article
CAS
PubMed
PubMed Central
Google Scholar
Thomas SV, Syam U, Devi JS. Predictors of seizures during pregnancy in women with epilepsy. Epilepsia. 2012;53(5):e85–8.
Article
PubMed
Google Scholar
Group ES. Seizure control and treatment in pregnancy: observations from the EURAP epilepsy pregnancy registry. Neurology. 2006;66(3):354–60.
Article
Google Scholar
Thomas SV, Sindhu K, Ajaykumar B, Sulekha Devi PB, Sujamol J. Maternal and obstetric outcome of women with epilepsy. Seizure. 2009;18(3):163–6.
Article
CAS
PubMed
Google Scholar
Sabers A, Petrenaite V. Seizure frequency in pregnant women treated with lamotrigine monotherapy. Epilepsia. 2009;50(9):2163–6.
Article
PubMed
Google Scholar
Cagnetti C, Lattanzi S, Foschi N, Provinciali L, Silvestrini M. Seizure course during pregnancy in catamenial epilepsy. Neurology. 2014;83(4):339–44.
Article
PubMed
Google Scholar
Abe K, Hamada H, Yamada T, Obata-Yasuoka M, Minakami H, Yoshikawa H. Impact of planning of pregnancy in women with epilepsy on seizure control during pregnancy and on maternal and neonatal outcomes. Seizure. 2014;23(2):112–6.
Article
PubMed
Google Scholar
Reisinger TL, Newman M, Loring DW, Pennell PB, Meador KJ. Antiepileptic drug clearance and seizure frequency during pregnancy in women with epilepsy. Epilepsy Behav. 2013;29(1):13–8.
Article
CAS
PubMed
PubMed Central
Google Scholar
Tomson T, Lindbom U, Ekqvist B, Sundqvist A. Epilepsy and pregnancy: a prospective study of seizure control in relation to free and total plasma concentrations of carbamazepine and phenytoin. Epilepsia. 1994;35(1):122–30.
Article
CAS
PubMed
Google Scholar
Bardy AH. Incidence of seizures during pregnancy, labor and puerperium in epileptic women: a prospective study. Acta Neurol Scand. 1987;75(5):356–60.
Article
CAS
PubMed
Google Scholar
Otani K. Risk factors for the increased seizure frequency during pregnancy and puerperium. Folia Psychiatr Neurol Jpn. 1985;39(1):33–41.
CAS
PubMed
Google Scholar
Gjerde IO, Strandjord RE, Ulstein M. The course of epilepsy during pregnancy: a study of 78 cases. Acta Neurol Scand. 1988;78(3):198–205.
Article
CAS
PubMed
Google Scholar
Hoeritzauer I, Mawhinney E, Irwin B, Hunt SJ, Morrow J, Craig J. Increased levetiracetam clearance in pregnancy: is seizure frequency affected? Seizure. 2012;21(7):559–60.
Article
CAS
PubMed
Google Scholar
Pennell PB, Peng L, Newport DJ, Ritchie JC, Koganti A, Holley DK, et al. Lamotrigine in pregnancy: clearance, therapeutic drug monitoring, and seizure frequency. Neurology. 2008;70(22 Pt 2):2130–6.
Article
CAS
PubMed
Google Scholar
Petrenaite V, Sabers A, Hansen-Schwartz J. Seizure deterioration in women treated with oxcarbazepine during pregnancy. Epilepsy Res. 2009;84(2–3):245–9.
Article
CAS
PubMed
Google Scholar
Brodtkorb E, Reimers A. Seizure control and pharmacokinetics of antiepileptic drugs in pregnant women with epilepsy. Seizure. 2008;17(2):160–5.
Article
PubMed
Google Scholar
Pennell PB. Antiepileptic drug pharmacokinetics during pregnancy and lactation. Neurology. 2003;61(6 Suppl 2):S35–42.
Article
CAS
PubMed
Google Scholar
Tomson T, Battino D, Bonizzoni E, Craig J, Lindhout D, Perucca E, et al. Withdrawal of valproic acid treatment during pregnancy and seizure outcome: observations from EURAP. Epilepsia. 2016;57(8):e173–7.
Article
CAS
PubMed
Google Scholar
Borthen I, Eide MG, Daltveit AK, Gilhus NE. Obstetric outcome in women with epilepsy: a hospital-based, retrospective study. BJOG. 2011;118(8):956–65.
Article
CAS
PubMed
Google Scholar
Viale L, Allotey J, Cheong-See F, Arroyo-Manzano D, McCorry D, Bagary M, et al. Epilepsy in pregnancy and reproductive outcomes: a systematic review and meta-analysis. Lancet. 2015;386(10006):1845–52.
Article
PubMed
Google Scholar
Lagana AS, Triolo O, D'Amico V, Cartella SM, Sofo V, Salmeri FM, et al. Management of women with epilepsy: from preconception to post-partum. Arch Gynecol Obstet. 2016;293(3):493–503.
Article
CAS
PubMed
Google Scholar
Yamasmit W, Chaithongwongwatthana S, Tolosa JE. Prenatal vitamin K1 administration in epileptic women to prevent neonatal hemorrhage: is it effective? J Reprod Med. 2006;51(6):463–6.
CAS
PubMed
Google Scholar
Kaaja E, Kaaja R, Matila R, Hiilesmaa V. Enzyme-inducing antiepileptic drugs in pregnancy and the risk of bleeding in the neonate. Neurology. 2002;58(4):549–53.
Article
CAS
PubMed
Google Scholar
Ohman I, Vitols S, Luef G, Soderfeldt B, Tomson T. Topiramate kinetics during delivery, lactation, and in the neonate: preliminary observations. Epilepsia. 2002;43(10):1157–60.
Article
PubMed
Google Scholar
Johannessen SI, Helde G, Brodtkorb E. Levetiracetam concentrations in serum and in breast milk at birth and during lactation. Epilepsia. 2005;46(5):775–7.
Article
CAS
PubMed
Google Scholar
Meador KJ, Baker GA, Browning N, Cohen MJ, Bromley RL, Clayton-Smith J, et al. Breastfeeding in children of women taking antiepileptic drugs: cognitive outcomes at age 6 years. JAMA Pediatr. 2014;168(8):729–36.
Article
PubMed
PubMed Central
Google Scholar